University of Wisconsin
Hematology and Oncology fellowship · Madison, WI · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Wisconsin–Madison's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
About University of Wisconsin–Madisoninstitution-wide hematology and oncology research
Hematology and Oncology publications from University of Wisconsin–Madison and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
217
works per year
24th of 74 hematology and oncology fellowship programs
+8.7%
2-year growth
45th of 74 hematology and oncology fellowship programs
26.4%
in top 10% of field (works before 2025)
29th of 72 hematology and oncology fellowship programs
47.7%
cited above world average
21st of 72 hematology and oncology fellowship programs
Works per year · * 2026 so far
Oncology · 790Hematology · 292
Hematology and Oncology research topics at University of Wisconsin–Madison
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 116
- CAR-T cell therapy research 91
- Multiple Myeloma Research and Treatments 83
- Cancer survivorship and care 78
- Pancreatic and Hepatic Oncology Research 76
- Hematopoietic Stem Cell Transplantation 76
- Acute Myeloid Leukemia Research 63
- Global Cancer Incidence and Screening 52
Most cited at University of Wisconsin–Madison since 2024
All hematology and oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyAl B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 406
- NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024Al B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 312
- Analysis of Breast Cancer Mortality in the US—1975 to 2019Jennifer Lee Caswell-Jin et al. · JAMA · 2024 · PubMed · cited 290
- Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark Robert Litzow et al. · New England Journal of Medicine · 2024 · PubMed · cited 288
- Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyJaffer A. Ajani et al. · Journal of the National Comprehensive Cancer Network · 2025 · PubMed · cited 243
- JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaJaroslav Žák et al. · Science · 2024 · PubMed · cited 204
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024Susan M. Swetter et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 173
- NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024John A. Thompson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 171